Lunit宣布与10x Genomics合作,共推AI病理学及肿瘤空间分子数据分析

美股速递
Yesterday

Lunit今日宣布,已与10x Genomics, Inc.达成战略合作,旨在将AI病理学与空间分子数据相结合,全面推动肿瘤学研究迈向新高度。此次合作将整合双方优势,深度融合组织图像分析与分子表达信息,为精准医疗提供更全面的决策支持。通过结合10x Genomics在单细胞及空间转录组学领域的领先技术,Lunit的AI病理平台有望获得全新的数据维度,从而更精准地识别肿瘤微环境及细胞间互动机制。这一举措,无疑将为癌症诊断和治疗开辟新的可能性。双方表示,合作将聚焦于临床前研究与转化医学,加速发现具有临床价值的生物标志物。此次携手,亦标志着AI病理学从形态学分析,向多组学整合方向迈出关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10